570 — China Traditional Chinese Medicine Holdings Co Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapNeutral

Market Cap
HK$10.17bn
Enterprise Value
HK$11.67bn
Revenue
CNY16.51bn

Annual income statement for China Traditional Chinese Medicine Holdings Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	R2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	HKAS	HKAS	HKAS	HKAS	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	14,806	19,053	14,304	18,122	16,510
Cost of Revenue
Gross Profit	9,126	11,829	7,198	9,274	7,856
Selling / General / Administrative Expenses
Research And Development
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	12,316	16,300	13,240	16,695	16,174
Operating Profit	2,491	2,753	1,064	1,427	336
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	2,230	2,520	840	1,225	163
Provision for Income Taxes
Net Income After Taxes	1,861	2,123	721	1,396	20.8
Minority Interest
Net Income Before Extraordinary Items
Net Income	1,663	1,933	764	1,285	54.1
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	1,663	1,933	764	1,285	54.1
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.342	0.387	0.182	0.254	0.071
Dividends per Share
Special Dividends per Share